Author

Laura Seclì

Observed names: L Seclì, L. Seclì, SECLI', LAURA

Institution: Nouscom (Italy)

Observed institutions: Nouscom (Italy), University of Turin

ORCID: 0000-0001-7129-3355

Observed ORCID: 0000-0001-7129-3355

OpenAlex ID: A5075548163

The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis

2017 · Federica Fusella, Laura Seclì, et al. · Nature Communications · 92

PDF

The dark-side of the outside: how extracellular heat shock proteins promote cancer

2021 · Laura Seclì, Federica Fusella, et al. · Cellular and Molecular Life Sciences · 75

PDF

Personalized Cancer Vaccines Go Viral: Viral Vectors in the Era of Personalized Immunotherapy of Cancer

2023 · Laura Seclì, Guido Leoni, et al. · International Journal of Molecular Sciences · 45

PDF

Extracellular HSP90 Machineries Build Tumor Microenvironment and Boost Cancer Progression

2021 · Pietro Poggio, Matteo Sorge, et al. · Frontiers in Cell and Developmental Biology · 41

PDF

Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity

2021 · Laura Seclì, Lidia Avalle, et al. · Cancer Research · 39

PDF

The Microrna-143/145 Cluster in Tumors: A Matter of Where and When

2020 · Valeria Poli, Laura Seclì, et al. · Cancers · 37

PDF

The one thousand and one chaperones of the NF-κB pathway

2019 · Federica Fusella, Laura Seclì, et al. · Cellular and Molecular Life Sciences · 34

Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial

2026 · Anna Morena D’Alise, Jason Willis, et al. · Nature Medicine · 33

PDF

Master Regulators of Muscle Atrophy: Role of Costamere Components

2021 · Luisa Gorza, Matteo Sorge, et al. · Cells · 32

PDF

Shedding Light on NF-κB Functions in Cellular Organelles

2022 · Giovanna Carrà, Lidia Avalle, et al. · Frontiers in Cell and Developmental Biology · 31

PDF

Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine

2024 · Irene Garzia, Linda Nocchi, et al. · Cancer Immunology Research · 14

PDF

Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer

2023 · Anna Morena D’Alise, Linda Nocchi, et al. · Frontiers in Immunology · 14

PDF

The double face of Morgana in tumorigenesis

2015 · Mara Brancaccio, Stefania Rocca, et al. · Oncotarget · 10

PDF

Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity

2023 · Laura Seclì, Luigia Infante, et al. · Journal for ImmunoTherapy of Cancer · 7

PDF

Neoadjuvant personalized viral vaccine prevents tumor relapse in checkpoint-resistant murine melanoma model

2025 · Laura Seclì, Linda Nocchi, et al. · Journal for ImmunoTherapy of Cancer · 5

Blocking Extracellular Chaperones to Improve Cardiac Regeneration

2020 · Laura Seclì, Matteo Sorge, et al. · Frontiers in Bioengineering and Biotechnology · 4

PDF

Escaping NK cells and recruiting neutrophils: How Morgana/NF-κB signaling promotes metastasis

2018 · Federica Fusella, Laura Seclì, et al. · Molecular & Cellular Oncology · 4

PDF

Abstract B053: Neoadjuvant Personalized Viral Vectored vaccines are highly effective against tumor relapse in checkpoint inhibitor resistant murine models

2024 · Anna Morena D'Alise, Laura Seclì, et al. · Cancer Immunology Research · 1

Supplementary Figure 5 from Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine